Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mid-titer human convalescent plasma administration results in suboptimal prophylaxis against SARS-CoV-2 infection in rhesus macaques

Frontiers in Immunology(2023)10.3389/fimmu.2023.1085883Source: DataRank Database

Mid-titer human convalescent plasma administration results in suboptimal prophylaxis against SARS-CoV-2 infection in rhesus macaques is a research paper published in Frontiers in Immunology (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.17)OA: goldTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Nicholas J. Maness ORCID,Skye Spencer ORCID,Jay Rappaport ORCID,Pyone P. Aye ORCID,Kasi Russell‐Lodrigue ORCID

Live enrichment

PubMed:36845143 PMC:PMC9950397 OpenAlex:https://openalex.org/W4319984369

National Institutes of Health

Grant: HHSN272201700033I

National Institutes of Health

Grant: OD011104

NIH HHS

Grant: P51 OD011104

National Institutes of Health

Grant: 3P51OD011104-58S2

Developing a more rapid model of aging in rhesus macaques of Alzheimer's disease research

FWCI

0.17

Citation Percentile

0.4%

Citation Trend

2025

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1085883/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1085883/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1085883/full

journalhttps://doi.org/10.3389/fimmu.2023.1085883

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36845143

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesDermatological and COVID-19 studies0301 basic medicine03 medical and health sciencesAnimalsHumansCOVID-19Macaca mulattaSARS-CoV-2Immunization, PassiveCOVID-19 Serotherapy

MeSH Terms

COVID-19SARS-CoV-2COVID-19 SerotherapyAnimalsHumansImmunization, PassiveMacaca mulatta

Keywords

Convalescent plasmaTiterVirologyMedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Immunology2019-20 coronavirus outbreakVirusInternal medicineInfectious disease (medical specialty)DiseaseOutbreakRhesus macaqueProphylaxisCovid-19Sars-cov-2Immunization, PassiveRC581-607Macaca mulattaAnimalsHumansImmunologic diseases. AllergyCOVID-19 Serotherapy

Sustainable Development Goals

SDG 0: Good health and well-being

Mid-titer human convalescent plasma administration results in suboptimal prophylaxis against SARS-CoV-2 infection in rhesus macaques

FAIR Checklist

Authors (11)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)